Centro de Inmunologia Molecular (CIM)
Patent Applications and Registrations
Patent applications and USPTO patent grants for Centro de Inmunologia Molecular (CIM).The latest application filed is for "immunomodulator polypeptides derived from il-2 and their use thereof in the therapeutic of cancer and chronic infections".
- Centro de Inmunologia Molecular (CIM) - CIM
- CENTRO DE INMUNOLOGIA MOLECULAR (CIM) - Habana CU
| Patent | Date |
|---|---|
| Homogeneous vaccine composition comprising a conjugate of EGF and P64K for the treatment of tumors Grant 8,778,879 - Rodriguez Martinez , et al. July 15, 2 | 2014-07-15 |
| Ganglioside associated recombinant antibodies and the use thereof in the treatment of tumors Grant 8,758,753 - June 24, 2 | 2014-06-24 |
| Ganglioside based vaccine compositions for subcutaneous administration Grant 8,591,917 - Molina , et al. November 26, 2 | 2013-11-26 |
| Immunomodulator Polypeptides Derived From Il-2 And Their Use Thereof In The Therapeutic Of Cancer And Chronic Infections App 20120315245 - Leon Monzon; Kalet ; et al. | 2012-12-13 |
| Anti-CD6 monoclonal antibodies and their uses Grant 6,572,857 - Casimiro , et al. June 3, 2 | 2003-06-03 |
| Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it Grant 6,429,295 - Carr Perez , et al. August 6, 2 | 2002-08-06 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 